Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 20 Lung Neoplasms 15 Carcinoma, Hepatocellular 13 Urinary Bladder Neoplasms 11 Colorectal Neoplasms 11 Small Cell Lung Carcinoma 9 Neoplasms 8 Carcinoma, Transitional Cell 8 Stomach Neoplasms 7 Neoplasm Metastasis 7 Breast Neoplasms 6 Triple Negative Breast Neoplasms 5 Melanoma 5 Prostatic Neoplasms 4 Glioblastoma 4 Carcinoma, Renal Cell 4 Uterine Cervical Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Ovarian Neoplasms 3 Carcinoma, Neuroendocrine 3 Urethral Neoplasms 2 Ureteral Neoplasms 2 Turcot syndrome 2 Solid Tumors 2 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Nasopharyngeal Carcinoma 2 Mesothelioma, Malignant 2 Lymphoma, Follicular 2 Glioma 2

Interventions

Surgical Procedures, Operative 2 Paclitaxel 2 Doxorubicin 2 Cyclophosphamide 2 Carboplatin 2 pertuzumab 1 liposomal doxorubicin 1 cemiplimab 1 atezolizumab 1 Trastuzumab 1 Radiotherapy 1 Indocyanine Green 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Invasive Breast Cancer × atezolizumab × Clear all

NCT03595592 2024-03-06

APTneo

Fondazione Michelangelo

Phase 3 Active not recruiting

Invasive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡